Results of our study demonstrate that analysis of NGS gene panel assays for CNVs can not only establish a genetic diagnosis (such as identifying RPL5 mutations in patients with DBA), but can also identify the specific diagnosis in unclassified or idiopathic bone marrow failure syndromes. This evidence concerns the gene RPL5 and bone marrow failure syndrome.